Developing medication isnt as big-ticket as they are saying:
Big Pharma company exaggerates the prices of R&D of recent medicines to justify their high evaluation, and infrequently categorize ‘opportunity costs’ and non-research activities, like the price of shopp...
Register with Industry Global News24 & Support the future of cogent journalism. One-time registration allows access to limitless articles free of cost!
